Tigecycline May Selectively Target Leukemic Stem Cells in CML [Leukemia]

Tigecycline inhibits mitochondrial oxidative phosphorylation to target leukemic stem cells (LSC).
Source: Cancer Discovery - Category: Cancer & Oncology Tags: Leukemia Source Type: research